Skip to search formSkip to main contentSkip to account menu

Levofloxacin

Known as: Levofloxacinum, Ofloxacin S-(-)-form, L-ofloxacin 
A broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin… 
National Institutes of Health

Related topics

Related topics

45 relations

Broader (3)

Anti-Bacterial AgentsAnti-Infective Agents, UrinaryTopoisomerase II Inhibitors
Bacterial InfectionsBronchitisChlamydia InfectionsDecreased Protein Synthesis [PE]

Narrower (3)

DR-3355LevaquinQuixin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
Highly Cited
2015
Highly Cited
2015
Duration of Antibiotic Treatment in Community-Acquired Pneumonia
Highly Cited
2014
Highly Cited
2014
Simultaneous determination of most prescribed antibiotics in multiple urban wastewater by SPE-LC-MS/MS.
Highly Cited
2011
Highly Cited
2011
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Highly Cited
2010
Highly Cited
2010
Detection of antibiotic resistance and tetracycline resistance genes in Enterobacteriaceae isolated from the Pearl rivers in South China.
Highly Cited
2006
Highly Cited
2006
Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
Review
2005
Review
2005
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections.
Review
2003
Review
2003
Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics.
Review
2002
Review
2002
Resistance among Streptococcus pneumoniae: Implications for drug selection.
Streptococcus pneumoniae is an important pathogen in many community-acquired respiratory infections in the United States and a… 
Highly Cited
1998
Highly Cited
1998
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
CONTEXT One purpose of early clinical trials is to establish the appropriate dose of an antibiotic for phase 3 trials… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)